It is not the first-choice injectable for uncomplicated Type 2 diabetes anymore, and understanding this shift helps explain why the GLP-1 question comes up so often
Tirzepatide (Mounjaro) Reimbursement Review CDA-AMC Canada's Drug Agency review of tirzepatide (Mounjaro), covering clinical evidence and price/reimbursement context for Canadian payers
Alcohol, a known irritant to the gastrointestinal system, can exacerbate these symptoms
The Role of Obesity in Type 2 Diabetes MellitusAn Overview
Microdosing may be a fit for women who: Are in perimenopause or menopause and experiencing weight changes, increased cravings, or energy dips Want a gentle, adjustable approach to GLP-1 therapy Prefer pairing medication with lifestyle strategies (nutrition, strength training, hormone therapy) Have no major contraindications to GLP-1 medications When Were More Cautious We may recommend holding off or exploring other options if you have: A personal or family history of medullary thyroid carcinoma or MEN2 A history of pancreatitis Significant gastrointestinal disorders that may be worsened by GLP-1 use Protecting Muscle & Metabolic Health While on GLP1 One of the biggest concerns with any weight-management medication is the potential loss of lean muscle mass

Step 6: Label the Bottle With Full Documentation At minimum, your label should include: the name of the compound, the concentration per actuation (in mcg per spray), the total volume in the bottle, the diluent used, and the date of reconstitution